QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)
QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)
QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)
QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)
NASDAQ:GUTS

Fractyl Health (GUTS) Stock Price, News & Analysis

$6.75
+0.24 (+3.69%)
(As of 02:45 PM ET)
Today's Range
$6.54
$7.18
50-Day Range
$6.25
$11.10
52-Week Range
$5.75
$14.50
Volume
65,001 shs
Average Volume
400,860 shs
Market Capitalization
$323.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00

Fractyl Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
221.6% Upside
$22.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.37mentions of Fractyl Health in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$5 M Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.88) to ($2.02) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.06 out of 5 stars

Medical Sector

813th out of 928 stocks

Surgical & Medical Instruments Industry

86th out of 99 stocks

GUTS stock logo

About Fractyl Health Stock (NASDAQ:GUTS)

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.

GUTS Stock Price History

GUTS Stock News Headlines

Fractyl Health Inc (GUTS)
Unusual Passive Income Investment (Found on a Golf Course)
Marc reveals how anyone can get into a similar opportunity for just $5.
Unusual Passive Income Investment (Found on a Golf Course)
Marc reveals how anyone can get into a similar opportunity for just $5.
GUTS Fractyl Health, Inc.
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
See More Headlines
Receive GUTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fractyl Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/15/2024
Next Earnings (Estimated)
7/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:GUTS
Previous Symbol
NASDAQ:GUTS
Fax
N/A
Employees
88
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.00
High Stock Price Target
$26.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+221.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$120,000.00

Miscellaneous

Free Float
N/A
Market Cap
$327.50 million
Optionable
N/A
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Harith Rajagopalan M.D. (Age 47)
    Ph.D., Co-Founder, CEO & Director
    Comp: $863.77k
  • Mr. Jay D. Caplan BSEE (Age 62)
    MBA, Co-Founder, Chief Product Officer & President
    Comp: $555.19k
  • Dr. Timothy J. Kieffer Ph.D. (Age 58)
    Chief Scientific Officer
    Comp: $140.64k
  • Ms. Lisa A. Davidson MBA (Age 58)
    CFO & Treasurer
  • Ms. Sarah S. Toomey Esq. (Age 49)
    General Counsel & Corporate Secretary
    Comp: $479.36k
  • Dr. Helmut Giersiefen
    Head of Business Development

GUTS Stock Analysis - Frequently Asked Questions

Should I buy or sell Fractyl Health stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fractyl Health in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GUTS shares.
View GUTS analyst ratings
or view top-rated stocks.

What is Fractyl Health's stock price target for 2024?

3 Wall Street analysts have issued 12-month price targets for Fractyl Health's stock. Their GUTS share price targets range from $18.00 to $26.00. On average, they expect the company's share price to reach $22.00 in the next twelve months. This suggests a possible upside of 221.6% from the stock's current price.
View analysts price targets for GUTS
or view top-rated stocks among Wall Street analysts.

How have GUTS shares performed in 2024?

Fractyl Health's stock was trading at $12.85 on January 1st, 2024. Since then, GUTS stock has decreased by 46.8% and is now trading at $6.84.
View the best growth stocks for 2024 here
.

When is Fractyl Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 1st 2024.
View our GUTS earnings forecast
.

When did Fractyl Health IPO?

Fractyl Health (GUTS) raised $110 million in an initial public offering on Friday, February 2nd 2024. The company issued 7,333,333 shares at $15.00 per share.

When did Fractyl Health's quiet period expire?

Fractyl Health's quiet period expired on Wednesday, March 13th. Fractyl Health had issued 7,333,333 shares in its initial public offering on February 2nd. The total size of the offering was $109,999,995 based on an initial share price of $15.00. During Fractyl Health's quiet period, insiders and any underwriters involved in the IPO were prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Fractyl Health?

Shares of GUTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GUTS) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners